Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00698854 · ClinicalTrials.gov registry record
A Clinical Investigation of the Vanguard™ Complete Knee System
A clinical trial, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 552
- Enrollment target
NCT00698854: Completed study, sponsored by Zimmer Biomet.
NCT00698854 is a clinical trial that has completed, run by Zimmer Biomet. The registered enrollment target is 552 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00698854 has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 552 participants
- Enrollment target
Study Summary
The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Vanguard™ Complete Knee System.
Primary Outcome
Knee Society Score Assessment
Interventions
- DEVICE Vanguard™ Complete Knee System
- DEVICE Vanguard™ Patient-Specific Femur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 552 participants |
| Start Date | 2004-03 |
| Est. Completion | 2024-03 |
What the finished NCT00698854 record still lists
NCT00698854 is an observational study that tracks outcomes without assigning an intervention. The registered 552 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Vanguard™ Complete Knee System is the first listed.
NCT00698854 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00698854 about?
NCT00698854 is a clinical study titled "A Clinical Investigation of the Vanguard™ Complete Knee System". The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Vanguard™ Complete Knee System.
What is the current status of trial NCT00698854?
This trial is currently completed. The enrollment target is 552 participants. The study started on 2004-03. Estimated completion is 2024-03.
What interventions are being tested in trial NCT00698854?
The interventions under investigation include: Vanguard™ Complete Knee System (DEVICE), Vanguard™ Patient-Specific Femur (DEVICE).
Who is sponsoring clinical trial NCT00698854?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06217809 · 552 participants · NA
EmpowHer is Prevention Curriculum for Youth Ages 10-15 Years.
- NCT07146022 · 552 participants · Phase 3
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
- NCT05786924 · 554 participants · Phase 1
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia